Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Product warranties, where applicable, are handled directly by the manufacturer according to the manufacturers warranty terms and conditions
The system was trained with a series of standard solutions of cyclic-di-GMP and the limit of detection limit was determined
Its development program was halted after Phase 2b trials, and it never reached approval as an obesity medication
This multi-axis neuroendocrine regulatory profile positions DSIP as a broad hypothalamic-pituitary axis modulator, not merely a sleep-specific peptide, and makes it a research tool for studying the neuroendocrine consequences of altered sleep homeostasis and circadian rhythm disruption
This peptides ability to restore neurotransmitter balance highlights its promise as a novel therapeutic agent for sleep disorders
